167
Vargha-Khadem F. et al. 1997. Differential effects of early hippocampal pathology on episodic and semantic memory. Science 277: 376–380.
168
Hakem R. et al. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339–352.
169
Ridley M. 1996. The origin of virtue. Viking, London;
Raff M. 1998. Cell suicide for beginners. Nature 396: 119–122.
170
Cookson W. 1994. The gene hunters: adventures in the genome jungle. Aurum Press, London.
171
Robert Weinberg 1998. One renegade cell. Weidenfeld and Nicolson, London.
172
Levine A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
173
Lowe S. W. 1995. Cancer therapy and p53. Current Opinion in Oncology 7: 547–553.
174
Hüber A.-O., Evan G. I. 1998. Traps to catch unwary oncogenes. Trends in Genetics 14: 364–367.
175
Cook-Deegan R. 1994. The gene wars: science, politics and the human genome. W. W. Norton, New York.
176
Krakauer D. C., Payne R. J. 1997. The evolution of virus-induced apoptosis. Proceedings of the Royal Society of London, Series B 264: 1757–1762.
177
Verma I. M., Somia N. 1997. Gene therapy — promises, problems and prospects. Nature 389: 239–242.
178
Capecchi M. R. 1989. Altering the genome by homologous recombination. Science 244: 1288–1292.
179
First N., Thomson J. 1998. From cows stem therapies? Nature Biotechnology 16: 620–621.
180
Lyon J., Corner P. 1996. Altered fates. Norton, New York.
181
Eto M., Watanabe K., Makino I. 1989. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease. Clinical Genetics 36: 183–188.
